Plasma Therapy Market Worth $882.5 Million by 2028 - Exclusive Report by Meticulous Research®

In a recent market analysis report titled "Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes) - Global Forecast to 2028", published by Meticulous Research®, the plasma therapy market is anticipated to witness a robust growth trajectory, projecting a Compound Annual Growth Rate (CAGR) of 12.2% from 2021 onwards, aiming to reach a valuation of $882.5 million by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5218

The expansion of the plasma therapy market is primarily attributed to various factors, including the advantages associated with Platelet-rich Plasma (PRP) treatment, heightened awareness surrounding PRP therapies, the escalating prevalence of musculoskeletal, sports, and orthopedic injuries, as well as the surging demand for cosmetic procedures on a global scale. Furthermore, the increasing adoption of PRP treatments and advancements in healthcare infrastructure within emerging economies are anticipated to present significant growth avenues for plasma therapy providers.

Nevertheless, factors such as the availability of alternatives to PRP treatment and potential side-effects associated with PRP may somewhat impede the market's growth trajectory during the forecast period. Additionally, the stringent regulatory landscape governing PRP usage represents a notable challenge within this market domain.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5218

The global landscape of PRP therapy products witnessed substantial disruptions amidst the COVID-19 pandemic, affecting manufacturers, business proprietors, and suppliers across both developed and developing economies. Particularly, low- and middle-income countries encountered formidable obstacles due to inadequacies in healthcare infrastructure and regulatory constraints imposed by authorities on industries and suppliers. The pandemic induced a significant downturn in demand for PRP therapies in regenerative medicine and pain management, encompassing conditions such as tennis elbow, arthritis, torn ligaments, as well as cosmetic and plastic surgeries.

The Southeast Asian region bore a severe brunt of the pandemic's repercussions, as several countries in this locality heavily rely on revenue generated from exports and tourism. Furthermore, medical tourism witnessed substantial setbacks due to travel restrictions, exemplified by the drastic decline in revenues reported by the Malaysian Health Tourism Council (MHTC) in 2020 compared to the preceding year. The adverse impact on health tourism translated into diminished adoption of PRP treatments, thereby reducing the usage of PRP products.

Nevertheless, a surge in research focusing on PRP for COVID-related treatments has been observed. Notably, a study published in a scientific journal in July 2021 conducted in Indonesia in collaboration with various universities and hospitals explored the efficacy of intravenous autologous activated platelet-rich plasma therapy on profibrotic cytokine in severe and critical COVID-19 patients. The findings highlighted the potential of PRP in mitigating pulmonary fibrosis post-recovery from severe COVID-19 cases, thereby facilitating lung function improvement. This research resurgence on PRP contributed to market recovery and growth.

Quick Buy - Plasma Therapy Market Research Report: https://www.meticulousresearch.com/Checkout/88849114

The plasma therapy market is categorized based on various parameters including type (pure platelet-rich plasma, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte & platelet-rich fibrin), application (orthopedics and traumatology, dermatology and cosmetology, rheumatology, stomatology and odontology, ophthalmology, among others), end user (hospitals & clinics, research institutes), and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa). The report also assesses industry competitors and their market share at both global and regional levels.

By type, the pure PRP segment is anticipated to dominate the plasma therapy market owing to its distinct advantages over conventional PRP treatments, facilitated by a meticulous two-step concentration process eliminating red blood cells and neutrophils.

Based on application, the orthopedics & traumatology segment is projected to hold the largest market share in 2021, driven by an increasing incidence of musculoskeletal disorders and the endorsement of PRP therapy as an adjunct treatment for various conditions including fractures and chronic pain.

Regarding end user, hospitals & clinics are anticipated to command a larger market share in 2021, attributed to the widespread utilization of platelet-rich plasma therapy across a spectrum of applications including pain management, regenerative medicine, joint & bone surgeries, cosmetic enhancements, hair growth, and sports injuries.

Geographically, North America is poised to lead the global plasma therapy market in 2021, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The dominant market share of North America is ascribed to several factors including the presence of leading PRP providers, a substantial patient pool with orthopedic ailments, government support, and burgeoning adoption of PRP in cosmetic and dermatologic applications.

Key companies operating in the global plasma therapy market are Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.) among others.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/plasma-therapy-market-5218

Scope of the Report

Plasma Therapy Market, by Type

Pure PRP
Leukocyte-rich PRP
Pure Platelet Rich Fibrin
Leukocyte and Platelet Rich Fibrin

Plasma Therapy Market, by Application

Orthopedics and Traumatology
Dermatology and Cosmetology
Rheumatology
Stomatology and Odontology
Ophthalmology
Others
(Note: Other applications include sexual health, infertility support, migraine, and neurological issues)

Plasma Therapy Market, by End User

Hospitals & Clinics
Research Institutes

Plasma Therapy Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Brazil
Mexico
Argentina
Rest of LATAM (RoLATAM)
Middle East & Africa

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since its inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/

This release was published on openPR.